A high-stakes vote just unlocked the exit of a cancer-focused subsidiary. But the real story is what this microcap does next.
With one chapter closed, investors are eyeing a pivot that could reshape its entire biotech trajectory.

Crypto Plays (Sponsored)
Five years ago, hardly anyone cared about Michael Saylor. His software firm was fading. Its cash pile was shrinking in value.
Then he shocked Wall Street: he put it all into Bitcoin.
The stock skyrocketed. MicroStrategy became the world’s largest Bitcoin treasury. Today it’s valued near $100 billion.
But here’s what most investors miss: Bitcoin can’t be staked. It doesn’t earn yield. It just sits there.
Now the same playbook is being applied to a different digital asset — one that does generate cash flow.
BNB.
The native token of Binance, the largest crypto exchange with 280 million users. It fuels transactions, reduces fees, anchors DeFi, and supports stablecoin flows larger than Ethereum. Binance systematically burns it, making it scarcer each quarter.
And unlike Bitcoin, BNB pays yield. A treasury this size can run validator nodes, stake tokens, and earn ongoing rewards — millions annually — while still benefiting from appreciation.
One company has already deployed $368 million into BNB, building the largest BNB treasury in the world.
Yet Wall Street still hasn’t priced it in.
This is the kind of setup insiders dream of: limited downside, asymmetric upside, and a productive asset at the center.
Unlock the name and symbol of this digital currency treasury now.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Markets
U.S. stocks ended slightly higher on Tuesday as investors balanced weak economic data and the looming threat of a government shutdown with hopes for a more dovish Fed amid stretched valuations.
The S&P 500 and Nasdaq saw their best September in over 15 years.
DJIA [+0.18%]
S&P 500 [+0.41%
Nasdaq [+0.30%]
Russell 2k [-0.17%]

Market-Moving News
Retail
Chewy’s Secret Weapon? Your Dog Doesn’t Do Recessions

Chewy (NYSE: CHWY) just pulled off another solid quarter, with sales climbing and customer loyalty holding steady.
The company even doubled down by buying back a big slice of its own stock — a sign it thinks the future looks brighter than Wall Street gives it credit for.
That’s why calling Chewy “boring” almost feels like a compliment. While markets swing on politics, tariffs, and inflation, pet owners just keep ordering food, toys, and treats on autopilot.
The Subscription Glue
Chewy’s model runs on repeat orders, which means predictable revenue.
You may not think much when that Chewy box shows up on your porch, but every delivery is another reason the company’s business looks bulletproof.
And for you, that means Chewy feels less like a gamble and more like a reliable habit.
People might cut back on vacations or gadgets, but nobody tells their cat the toys are canceled.
The Quiet Flex
Chewy’s leadership clearly knows what they’ve got; that big buyback was basically them saying, “yeah, we’re confident.” It’s not hype, it’s housekeeping.
So while everyone else chases the next shiny AI stock, you might want to peek at the company quietly making bank on chew toys.
Sometimes the “boring” aisle is where you find the treats.

Payments
When the Old Guard Steals the New Guard’s Playbook

Visa (NYSE: V) is testing a new way for businesses to send money across borders.
Instead of parking piles of cash in foreign bank accounts, they’ll be able to fund transactions with stablecoins.
If you’ve ever tried wiring money overseas, you know how clunky and expensive it can get. Visa’s saying, “What if we just skip the old wires and plug in crypto rails instead?”
Turning a Threat Into a Tool
For years, stablecoins have been hyped as a potential rival to Visa. Now, Visa is flipping that script by integrating them into its own system. That’s not defense, that’s offense.
And for you, it means the rails you already trust could soon run faster, cheaper, and smarter without you having to download five new apps just to pay someone in another country.
Why This Move Sets Up Visa
Here’s the kicker: every transaction that shifts onto Visa’s rails is money in its pocket.
By integrating stablecoins as a feature, Visa captures flows that might have otherwise gone to fintechs or crypto wallets and locks them within its network.
That’s how profits grow without adding new cards or new customers, just by handling more traffic on the same highways.
If the pilot works, Visa isn’t just staying relevant; it’s setting itself up to earn fees on the next decade of cross-border money movement.

Breakouts Are Near (Sponsored)
Your portfolio might be doing fine.
But why stop at fine when you could aim for game-changing gains?
Our analysts have just released a new special report, highlighting 5 stocks with the potential to double.
These aren’t random picks.
They were hand-selected because they combine:
Proven fundamentals with long-term staying power
Technical strength suggesting momentum is building now
Past reports have pinpointed stocks before huge runs of +175%, +498%, even +673%.¹
This exclusive report is yours free—but only until midnight tonight.
[Click here now to download your copy instantly]
Why settle for average when extraordinary is on the table?
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Manufacturing
Boeing Hints at a New Bird in the Hangar

Boeing (NYSE: BA) has nearly 6,000 commercial jets on order, a number that continues to grow, much like Everest, every quarter.
Clearing that backlog is the daily grind, but it’s also proof that airlines still trust the brand despite its bruises.
For you, that means Boeing isn’t short on demand. The real question is whether it can get planes out the door fast enough without tripping over production snags.
A Glimpse of Tomorrow
Here’s the fun part: Boeing is quietly floating the idea of building a brand-new single-aisle jet, a successor to the 737 MAX.
Just hinting at it is a shift after years of patching problems; Boeing is finally whispering about the future again.
Airbus has been cleaning up on single-aisle orders, so Boeing knows it can’t just play defense forever. If this new jet gets the green light, it’s a fresh chance to win back sky share.
Why It Matters Now
Boeing’s story has 1been stuck in a state of repair, marked by accidents, strikes, and delays.
But a new jet signals a pivot: fix today, bet on tomorrow. That’s the kind of balance that makes the comeback narrative real.
So while Airbus enjoys the lead, keep your eye on when Boeing stops hinting and actually commits. That moment isn’t just another plane launch; it’s the start of Boeing’s second act.

Want to make sure you never miss our post-market roundup?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone right after the closing bell rings.
Email’s great. Texts are faster.

Top Winners and Losers
SciSparc Ltd [SPRC] $6.01 (+34.94%)
SciSparc jumped after shareholders at N2OFF approved the acquisition of its oncology-focused subsidiary MitoCareX.
Bakkt Holdings Inc [BKKT] $33.64 (+31.66%)
Bakkt rallied after Benchmark more than tripled its price target, citing upside in its crypto infrastructure and stablecoin businesses.
Anaptysbio Inc [ANAB] $30.62 (+31.59%)
AnaptysBio surged after announcing plans to split into two publicly traded firms focused separately on drug development and royalty management.

Flora Growth Corp [FLGC] $17.27 (-22.00%)
Flora Growth, which is rebranding to ZeroStack, fell amid skepticism over a $401 million OG token treasury plan, which filings revealed was largely in-kind and not backed by real capital.
Artelo Biosciences Inc [ARTL] $4.59 (-21.54%)
Artelo dropped after announcing a discounted $2 million public offering, sparking dilution concerns among investors.
Firefly Aerospace Inc [FLY] $29.32 (-20.67%)
Shares plunged after a test of its Alpha rocket ended in failure, marking the second major setback in recent months and raising concerns over launch timelines.


Market Turning Point (Sponsored)
The clock is ticking.
2025’s final quarter could be the last big rally before the reset of 2026.
Markets are moving fast:
Fed signals hint at cuts
Oil shocks roil supply chains
AI & defense spending explode
We’ve zeroed in on 7 stocks primed to surge before year-end.
This isn’t noise, it’s your shot to finish 2025 ahead of the crowd. But wait too long, and Wall Street takes it first.
[Claim Your Free “Top 7 Stocks for Q4 2025” Guide Now]

Everything Else
AstraZeneca’s move toward a U.S. listing could tempt other London-listed firms to follow suit.
A $130 billion energy management giant is quietly powering Nvidia’s data center boom, proving even AI needs a serious electric bill sponsor.
Exxon will shed 2,000 jobs as part of a restructuring drive, affecting workers in Canada and the EU.
The S&P 500 slipped as Washington’s shutdown drama crept closer, reminding markets that politicians can tank momentum faster than bad earnings.
Amazon unveiled a refreshed device lineup, baking Alexa+ AI deeper into home gadgets and security.
U.S. drugmakers rallied after Trump announced Pfizer price cuts and promised more pharma deals ahead.
OpenAI debuted a new AI video tool built from copyrighted material, stirring fresh debate over fair use.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
1